Literature DB >> 29254528

Conflicts of Interest in Clinical Guidelines: Update of U.S. Preventive Services Task Force Policies and Procedures.

Quyen Ngo-Metzger1, Virginia Moyer2, David Grossman3, Mark Ebell4, Meghan Woo5, Therese Miller6, Tana Brummer5, Joya Chowdhury6, Elisabeth Kato6, Albert Siu7, William Phillips8, Karina Davidson9, Maureen Phipps10, Kirsten Bibbins-Domingo11.   

Abstract

The U.S. Preventive Services Task Force (USPSTF) provides independent, objective, and scientifically rigorous recommendations for clinical preventive services. A primary concern is to avoid even the appearance of members having special interests that might influence their ability to judge evidence and formulate unbiased recommendations. The conflicts of interest policy for the USPSTF is described, as is the formal process by which best practices were incorporated to update the policy. The USPSTF performed a literature review, conducted key informant interviews, and reviewed conflicts of interest policies of ten similar organizations. Important findings included transparency and public accessibility; full disclosure of financial relationships; disclosure of non-financial relationships (that create the potential for bias and compromise a member's objective judgment); disclosure of family members' conflicts of interests; and establishment of appropriate reporting periods. Controversies in best practices include the threshold of financial disclosures, ease of access to conflicts of interest policies and declarations, vague definition of non-financial biases, and request for family members' conflicts of interests (particularly those that are non-financial in nature). The USPSTF conflicts of interest policy includes disclosures for immediate family members, a clear non-financial conflicts of interest definition, long look-back period and application of the policy to prospective members. Conflicts of interest is solicited from all members every 4 months, formally reviewed, adjudicated, and made publicly available. The USPSTF conflicts of interest policy is publicly available as part of the USPSTF Procedure Manual. A continuous improvement process can be applied to conflicts of interest policies to enhance public trust in members of panels, such as the USPSTF, that produce clinical guidelines and recommendations.
Copyright © 2018 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2018        PMID: 29254528     DOI: 10.1016/j.amepre.2017.06.034

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  9 in total

1.  Conflicts of Interest and the Trustworthiness of Clinical Practice Guidelines.

Authors:  Anna Mathew; Catherine M Clase
Journal:  Clin J Am Soc Nephrol       Date:  2022-05-27       Impact factor: 10.614

2.  Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline.

Authors:  Anju Murayama; Kohki Yamada; Makoto Yoshida; Yudai Kaneda; Hiroaki Saito; Toyoaki Sawano; Sunil Shrestha; Rajeev Shrestha; Tetsuya Tanimoto; Akihiko Ozaki
Journal:  Clin J Am Soc Nephrol       Date:  2022-06       Impact factor: 10.614

3.  Examination of Potential Industry Conflicts of Interest and Disclosures by Contributors to Online Medical Resource Databases.

Authors:  SooYoung H VanDeMark; Mia R Woloszyn; Laura A Christman; Michael H Gatusky; Warren S Lam; Stephanie S Tilberry; Brian J Piper
Journal:  JAMA Netw Open       Date:  2022-07-01

4.  [Conflicts of interest in the medical profession].

Authors:  Rogelio Altisent; María-Teresa Delgado-Marroquín; María-Pilar Astier-Peña
Journal:  Aten Primaria       Date:  2019-06-24       Impact factor: 1.137

5.  Managing conflicts of interest in the development of health guidelines.

Authors:  Gregory Traversy; Lianne Barnieh; Elie A Akl; G Michael Allan; Melissa Brouwers; Isabelle Ganache; Quinn Grundy; Gordon H Guyatt; Diane Kelsall; Gillian Leng; Ainsley Moore; Navindra Persaud; Holger J Schünemann; Sharon Straus; Brett D Thombs; Rachel Rodin; Marcello Tonelli
Journal:  CMAJ       Date:  2021-01-11       Impact factor: 8.262

6. 

Authors:  Gregory Traversy; Lianne Barnieh; Elie A Akl; G Michael Allan; Melissa Brouwers; Isabelle Ganache; Quinn Grundy; Gordon H Guyatt; Diane Kelsall; Gillian Leng; Ainsley Moore; Navindra Persaud; Holger J Schünemann; Sharon Straus; Brett D Thombs; Rachel Rodin; Marcello Tonelli
Journal:  CMAJ       Date:  2021-03-01       Impact factor: 8.262

7.  Self-reported Financial Conflict of Interest in Nephrology Clinical Practice Guidelines.

Authors:  Madhuri Chengappa; Sandra Herrmann; Thejaswi Poonacha
Journal:  Kidney Int Rep       Date:  2020-12-31

8.  A Quantitative and Narrative Evaluation of Goodman and Gilman's Pharmacological Basis of Therapeutics.

Authors:  Brian J Piper; Alexandria A Alinea; John R Wroblewski; Sara M Graham; Daniel Y Chung; Livia R M McCutcheon; Melissa A Birkett; Steven S Kheloussi; Vicky M Shah; John L Szarek; Qais K Zalim; John A Arnott; William A McLaughlin; Pamela A Lucchesi; Kimberly A Miller; Gabi N Waite; Michael Bordonaro
Journal:  Pharmacy (Basel)       Date:  2019-12-20

9.  Half a Century of Wilson & Jungner: Reflections on the Governance of Population Screening.

Authors:  Steve Sturdy; Fiona Miller; Stuart Hogarth; Natalie Armstrong; Pranesh Chakraborty; Celine Cressman; Mark Dobrow; Kathy Flitcroft; David Grossman; Russell Harris; Barbara Hoebee; Kelly Holloway; Linda Kinsinger; Marlene Krag; Olga Löblová; Ilana Löwy; Anne Mackie; John Marshall; Jane O'Hallahan; Linda Rabeneck; Angela Raffle; Lynette Reid; Graham Shortland; Robert Steele; Beth Tarini; Sian Taylor-Phillips; Bernie Towler; Nynke van der Veen; Marco Zappa
Journal:  Wellcome Open Res       Date:  2020-08-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.